Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (538)	5/4/1998 4:38:00 PM
From: SnowShredder	Read Replies (1) \| Respond to of 2135

Rick, "The author is a jerk." You crack me up. Nice article. Thanks. Congrats on cleaning house today...so when r u retiring? Best of Luck, Where'd He Go?

To: scaram(o)uche who wrote (538)	5/4/1998 8:27:00 PM
From: ubrx	Respond to of 2135

Rick, Thanks for the link. I am long on SCIO and missed the article last year. As for ENMD, I hope the product works as well in humans as it does in mice. IMO, even if all goes well for ENMD in trials the stock price will drop short term. The investing public does not have the patience to wait 5 years or so for this drug to get through human trials...at least not at this price. I am going to sit on the sidelines until the volume drops back down to the pre-hype levels then evaluate from there. Good luck to all. Jim